Cioboata, D.M.; Costescu, O.C.; Manea, A.M.; Doandes, F.M.; Zaharie, M.; Popa, Z.L.; Costescu, S.; Stoica, F.; Boia, M.
Predicting Retinopathy of Prematurity Risk Using Plasma Levels of Insulin-like Growth Factor 1 (IGF1), Tumor Necrosis Factor-Alpha (TNF-Alpha), and Neonatal Parameters. Clin. Pract. 2024, 14, 1515-1528.
https://doi.org/10.3390/clinpract14040122
AMA Style
Cioboata DM, Costescu OC, Manea AM, Doandes FM, Zaharie M, Popa ZL, Costescu S, Stoica F, Boia M.
Predicting Retinopathy of Prematurity Risk Using Plasma Levels of Insulin-like Growth Factor 1 (IGF1), Tumor Necrosis Factor-Alpha (TNF-Alpha), and Neonatal Parameters. Clinics and Practice. 2024; 14(4):1515-1528.
https://doi.org/10.3390/clinpract14040122
Chicago/Turabian Style
Cioboata, Daniela Mariana, Oana Cristina Costescu, Aniko Maria Manea, Florina Marinela Doandes, Mihaela Zaharie, Zoran Laurentiu Popa, Sergiu Costescu, Florina Stoica, and Marioara Boia.
2024. "Predicting Retinopathy of Prematurity Risk Using Plasma Levels of Insulin-like Growth Factor 1 (IGF1), Tumor Necrosis Factor-Alpha (TNF-Alpha), and Neonatal Parameters" Clinics and Practice 14, no. 4: 1515-1528.
https://doi.org/10.3390/clinpract14040122
APA Style
Cioboata, D. M., Costescu, O. C., Manea, A. M., Doandes, F. M., Zaharie, M., Popa, Z. L., Costescu, S., Stoica, F., & Boia, M.
(2024). Predicting Retinopathy of Prematurity Risk Using Plasma Levels of Insulin-like Growth Factor 1 (IGF1), Tumor Necrosis Factor-Alpha (TNF-Alpha), and Neonatal Parameters. Clinics and Practice, 14(4), 1515-1528.
https://doi.org/10.3390/clinpract14040122
